AFS Zorgapotheek

Active

Private limited companyfounded 2024active for 2 yearsElisabethlaan 156, 2600 Antwerpen, BelgiumKBO/BCE: BE 1007.931.354

Summary

The computed 12-month bankruptcy probability of AFS Zorgapotheek is 5.3% (elevated). The 2025 annual accounts show negative equity (-€908,397) and a net result of -€5.0m. Its solvency ranks better than 8% of 12,678 sector peers (NACE 47, financial year 2025). The company has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals.

Risk analysisFollow Report Compare

AFS ZorgapotheekActiveChecked score 34/100

Risk analysis Report Compare

Activity

Retail sale of pharmaceutical products

NACE 47730Retail sale of medical and orthopaedic goods, excluding prescription glasses and lenses NACE 47741

1 site

Size

€2.6mtotal assets 2025

Staff: 43.7 FTE
Equity: -€908,397
Loss: -€5.0m

Turnover not published (abbreviated format)

Financial health

34 Weak Checked score 2025

Bankruptcy probabilitywithin 12 months: 5.3%

Structure

Parent: AFS · 70%
Board: 6 members

J & LManaging director · permanent representative Jan Kuyps

Auditor: Moore Audit2025 accounts 36 days early

Why 34raises riskLoss of €5.0m (financial year 2025)1 change of registered office in 24 monthsNegative equity -€908,397lowers riskFigures for financial year 2025 (filed 26-06-2026)Show the evidence

Checked score

Score 2025

34 / 100

Weak

Probability in this band: 4.2% to 15.0%

Financially better than 4% of its sector peers (NACE 47, small)

Every signal that counts is listed under Signals.

Financial strength

Weak

Solvency 0

equity -35.4% of total assets

Liquidity 9

short-term debt 135.3% · cash 7.1%

Profitability 0

return on assets -192.9%

Bankruptcy probability, 12 months

5.3% Elevated

0%0.5%1.5%4%10%≥ 25%

About 5 in 100 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.4% (3,693 companies, NACE 47, small)

Last 24 months 05-2025: 1.8%lowest value 06-2025: 1.9%▲ +0.1 percentage points vs 05-2025 07-2025: 2.2%▲ +0.3 percentage points vs 06-2025 08-2025: 2.3%▲ +0.1 percentage points vs 07-2025 09-2025: 2.6%▲ +0.3 percentage points vs 08-2025 10-2025: 2.6%● unchanged vs 09-2025 11-2025: 2.9%▲ +0.3 percentage points vs 10-2025 12-2025: 2.9%● unchanged vs 11-2025 01-2026: 2.8%▼ -0.1 percentage points vs 12-2025 02-2026: 2.8%● unchanged vs 01-2026 03-2026: 3.2%▲ +0.4 percentage points vs 02-2026 04-2026: 5.5%▲ +2.3 percentage points vs 03-2026highest value 05-2026: 5.5%● unchanged vs 04-2026highest value 06-2026: 5.5%● unchanged vs 05-2026highest value 07-2026: 5.4%▼ -0.1 percentage points vs 06-2026 08-2026: 5.4%● unchanged vs 07-2026 09-2026: 5.4%● unchanged vs 08-2026 10-2026: 5.3%▼ -0.1 percentage points vs 09-2026

No credit on open account

Liquidity insufficient (current ratio 0.58, below 1; short-term debt: 135.3% and cash: 7.1% of total assets), and equity is negative.

How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100	Excellent	under 0.55%
60-74	Healthy	0.55% to 1.5%
45-59	Fair	1.5% to 4.2%
25-44	Weak	4.2% to 15.0%
0-24	Critical	over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, small): better than 2% on solvency, 7% on liquidity and 2% on profitability.

The bankruptcy probability was computed on 26-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Seven signals.

lowers riskraises riskneutral

Loss of €5.0m (financial year 2025)

NBB · annual accounts

Figures for financial year 2025 (filed 26-06-2026)

NBB · annual accounts

1 change of registered office in 24 months

Belgian Official Gazette

Negative equity -€908,397

NBB · annual accounts

Negative equity

The 2025 annual accounts show negative equity and a net loss.

NBB · annual accounts 2025

Young company

Founded in 2024, 2 years ago. Young companies fail more often than established ones; the risk is highest 2 to 8 years after founding.

KBO · incorporation date

Age against the risk zone

Latest accounts filed on time

The financial year that closed on 30-12-2025 was due by 30-07-2026 and was filed on 24-06-2026, 36 days ahead of the deadline.

NBB · 1 filing

Deviation from the deadline

2025

36 days early

← before the deadline after the deadline →

Searched, nothing found (1)

No strike-offs in the KBO publications

Searched since incorporation in 2024.

KBO publications · our coverage

24-06-2026 Annual accounts filedfinancial year 2025 · abbreviated…
11-05-2026 Resignations & appointmentsPower of attorney
11-03-2026 Resignations: Hilde De Wolf, Steven Hermans…Permanent representatives: Leo Deprince, Jan…

Key points

Risk: Negative equityfinancial year 2025: debts exceed assets -€908,397 View
Caution: Among the weakest 5% on net resultsector median €27,728 · 12,668 companies -€5.0m View
Board changedlatest change 30-12-2025 · 6 in office 3 joined · 2 left View
Controlled by AFS 70% View

By topic

Financials

Financial year: 2025
Total assets: €2.6m
Loss: -€5.0m
Solvency: -35.4%

Go to Financials

Board & ownership

Board: 6 members
Parent: AFS · 70%
Auditor: Moore Audit

HEYLEN Koen Alida JanDirector
AFSDirector
Antoine PirlotDirector
WiNaMiDirector
DEPRINCEDirector

and 1 other director

Go to Board & ownership

Network & group

Connected companies: 22

Go to Network & group

Timeline

Events: 10
Since: 2024

09-01-2026Amendment of the articles · Name
21-01-2025Resignation: Koen Heylen (director)
03-01-2025Resignation: Koen HEYLEN (director)

Go to Timeline

Company details

Sites: 1

Legal form: Private limited company
Activity: Retail sale of pharmaceutical productsNACE 47730
Founded: 03-04-2024
Year ends: 30-12
Peppol: Reachable for e-invoices

Go to Company details

Articles of association

Provisions read: 14

Who signs: Two directors jointly
Annual meeting: Second Tuesday of June at 18:00

Go to Articles of association

Key facts about AFS Zorgapotheek

What is the company number of AFS Zorgapotheek?: 1007.931.354. In Belgium the VAT number is the company number with BE in front: BE 1007.931.354.
Where is AFS Zorgapotheek based?: The registered office is at Elisabethlaan 156, 2600 Antwerpen.Company details
What does AFS Zorgapotheek do?: According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of AFS Zorgapotheek?: Private limited company (BV).
When was AFS Zorgapotheek founded?: On 03-04-2024.
Is AFS Zorgapotheek still active?: Yes, AFS Zorgapotheek is an active enterprise in the KBO register.
How many employees does AFS Zorgapotheek have?: On average 43.7 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of AFS Zorgapotheek?: Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.
Is AFS Zorgapotheek profitable?: In financial year 2025, AFS Zorgapotheek made a loss of €5.0m.
Where can I find the annual accounts of AFS Zorgapotheek?: AFS Zorgapotheek filed 1 annual account with the National Bank of Belgium, for financial year 2025.